Company Search:
Advanced Search
Sponsored Links
Repligen Corporation Company Snapshot
Repligen Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Repligen with three other companies in this sector in the United States: PDL Biopharma, Inc. (2018 sales of $198.11 million of which 47% was Income generating assets), Intrexon Corp ($160.57 million of which 100% was Synthetic Biology), and ANI Pharmaceuticals Inc ($201.58 million of which 100% was Pharmaceutical Products).

Sales Analysis. Repligen reported sales of $194.03 million for the year ending December of 2018. This represents an increase of 37.4% versus 2017, when the company's sales were $141.24 million. This was the fourth straight year of sales growth at Repligen.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Repligen Corporation
  Stock Performance Chart for Repligen Corporation
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 84.09
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks 8.6%  
4 Weeks -8.4%   52 Weeks 24.1%  
Repligen Corporation Key Data:
  Ticker: RGEN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 194,032,000
(Year Ending Jan 2019).
Employees: 548
  Currency: U.S. Dollars Market Cap: 4,377,101,536
  Fiscal Yr Ends: December Shares Outstanding: 52,052,581
  Share Type: Common Closely Held Shares: 4,492,739
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.